- €37.71bn
- €67.21bn
- €45.58bn
Annual balance sheet for Bayer AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,739 | 10,153 | 10,587 | 8,087 | 7,856 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12,980 | 13,450 | 12,522 | 12,188 | 12,170 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 32,578 | 37,760 | 37,556 | 34,444 | 32,911 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12,688 | 13,674 | 13,321 | 13,456 | 12,649 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 120,241 | 124,877 | 116,259 | 110,850 | 104,541 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 29,403 | 35,084 | 29,457 | 28,952 | 32,585 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 87,221 | 86,104 | 83,332 | 78,942 | 78,594 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 33,020 | 38,773 | 32,927 | 31,908 | 25,947 |
| Total Liabilities & Shareholders' Equity | 120,241 | 124,877 | 116,259 | 110,850 | 104,541 |
| Total Common Shares Outstanding |